Location History:
- Carmel, IN (US) (2021 - 2023)
- South San Francisco, CA (US) (2024)
Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Lynne Bannen
Introduction
Lynne Bannen is an accomplished inventor based in Carmel, IN, United States, with a strong focus on pharmaceutical innovations. With a total of three patents, she is dedicated to advancing medical treatments, particularly in regard to hepatitis B virus (HBV) infections.
Latest Patents
Among her most notable patents are formulations of 5-membered heteroaryl carboxamide compounds. These compounds are designed to disrupt the assembly of HBV core proteins and are a pivotal component in the development of treatments for hepatitis B. The pharmaceutical compositions created from her innovations hold promise for effectively addressing this critical health issue.
Career Highlights
Lynne Bannen's career is marked by her impactful work in the biotechnology sector. She plays a crucial role at Assembly Biosciences, Inc., where she contributes her expertise in creating novel therapeutic solutions. Her research has the potential to significantly improve patient outcomes in the treatment of HBV infections.
Collaborations
In her professional journey, Lynne collaborates with talented colleagues, including Leping Li and Simon Nicolas Haydar. These partnerships enhance her ability to innovate and drive forward the mission of Assembly Biosciences, Inc. Together, they work towards breakthroughs that can change the landscape of hepatitis B treatment.
Conclusion
Lynne Bannen is a noteworthy figure in the realm of pharmaceutical inventions. With her significant contributions and dedication to improving treatments for hepatitis B, she exemplifies the spirit of innovation that drives the industry forward. Her work not only addresses a critical health concern but also demonstrates the essential role of inventors in shaping the future of medicine.